Unknown NA INTERVENTIONAL 3-arm NCT04786535

Efficacy of Uremic Toxins Clearance With Expanded Hemodialysis

Crossover Study of Three Groups Comparing the Efficacy of Uremic Toxins Clearance of Expanded Hemodialysis With Two Hemodialysis Membranes for Conventional Hemodialysis and Hemodiafiltration

Sponsor: Baxter México

Conditions End Stage Renal Disease

Interventions Expanded Hemodialysis Hemodiafiltration High-flux Conventional Hemodialysis

Updated 5 times since 2021 Last updated: Sep 13, 2021 Started: May 10, 2021 Primary completion: Sep 6, 2021 Completion: Jan 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04786535, this NA trial focuses on End Stage Renal Disease and remains ongoing. Sponsored by Baxter México, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Oct 2021 — Oct 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2021 — Oct 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter México
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Data source: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico